Drug intelligence / Profile preview

codeine + oxycodone + IRcodone + tramadol

Development stage
Unknown
Lead developer
Merck
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Subcutaneous, Rectal
01

Overview

This is a combination of four opioid analgesics—codeine, oxycodone, IRcodone (no recognized pharmaceutical agent by this name), and tramadol. Codeine and oxycodone are classic opioids that act primarily as mu-opioid receptor agonists to provide analgesia for moderate to severe pain. Tramadol is a synthetic opioid with dual mechanisms of action; it acts as a weak mu-opioid receptor agonist and also inhibits the reuptake of serotonin and norepinephrine, contributing to its analgesic effects[1][3][4][5]. The combination would theoretically provide multimodal pain relief but significantly increases the risk for additive central nervous system depression, respiratory depression, overdose, dependence, and other serious adverse effects[2][7]. There is no evidence that such a four-drug combination exists as an approved or marketed product.

02

Targets

NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on codeine + oxycodone + IRcodone + tramadol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on codeine + oxycodone + IRcodone + tramadol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call